Show Menu

A fully integrated developer and manufacturer of polyclonal therapeutics, targeting infectious disease and acute toxic events


MicroPharm is pleased to announce that it has been awarded a SMART grant by the Welsh Development Agency to support its continued research into new applications of therapeutic ovine polyclonal antibodies. 

MicroPharm’s Chairman, Professor Landon, stated, “This grant will help MicroPharm accelerate the development of the Company’s product pipeline.  We are grateful to the Welsh Development Agency for their continued support.”  The terms of the award were not disclosed.

Posted on: Friday, 1st October 2010